Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies
C D Britten, E K Rowinsky, S D Baker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium
S G Eckhardt, H A Burris, J R Eckardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors
S G Diab, S D Baker, A Joshi, et al.
British Journal of Cancer
|
July 23, 2013
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
J J Arcaroli, K S Quackenbush, A Purkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
M L Rothenberg, J R Eckardt, J G Kuhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies
M Hidalgo, M A Villalona-Calero, S G Eckhardt, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
A Capasso, J Lang, T M Pitts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 1998
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
M L Rothenberg, A Sharma, G R Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
M L Rothenberg, J G Kuhn, L J Schaaf, et al.
Accident; Analysis and Prevention
|
November 5, 2025
The Manchester driving behavior questionnaire (DBQ) integrating health and technology factors: The DBQ 2025 update with translations in 11 languages
Sepideh Harzand-Jadidi, David C Schwebel, Ali Jafari-Khounigh, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies
C D Britten, E K Rowinsky, S D Baker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium
S G Eckhardt, H A Burris, J R Eckardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors
S G Diab, S D Baker, A Joshi, et al.
British Journal of Cancer
|
July 23, 2013
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
J J Arcaroli, K S Quackenbush, A Purkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
M L Rothenberg, J R Eckardt, J G Kuhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies
M Hidalgo, M A Villalona-Calero, S G Eckhardt, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
A Capasso, J Lang, T M Pitts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 1998
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
M L Rothenberg, A Sharma, G R Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
M L Rothenberg, J G Kuhn, L J Schaaf, et al.
Accident; Analysis and Prevention
|
November 5, 2025
The Manchester driving behavior questionnaire (DBQ) integrating health and technology factors: The DBQ 2025 update with translations in 11 languages
Sepideh Harzand-Jadidi, David C Schwebel, Ali Jafari-Khounigh, et al.
Page
of 10